1. INTRODUCTION:

The human body operates on precisely timed 24-hour biological cycles known as circadian rhythms, which govern critical physiological functions including sleep-wake cycles, hormone secretion, metabolic processes, and cellular regeneration. These endogenous rhythms, synchronized primarily by environmental light-dark cycles through the suprachiasmatic nucleus (SCN) of the hypothalamus, are fundamental to maintaining systemic homeostasis¹. Contemporary research reveals that disruptions to these circadian patterns contribute significantly to various modern health epidemics, particularly sleep disorders (including insomnia and shift work disorder), metabolic diseases (such as type 2 diabetes and obesity), and neuropsychiatric conditions, including major depressive disorder and Alzheimer's disease^2,3.

In therapeutic development, chronotherapy has emerged as an innovative treatment paradigm that optimizes clinical outcomes by temporally aligning pharmacological interventions with the body's endogenous biological rhythms. This approach capitalizes on circadian variations in drug pharmacokinetics and pharmacodynamics, potentially enhancing therapeutic efficacy while reducing adverse effects⁴. The field represents a transformative shift from conventional treatment models toward precision medicine approaches that consider individual circadian phenotypes.

Ocimum sanctum Linn. (Holy Basil or Tulsi), a premier adaptogenic herb in Ayurvedic medicine, demonstrates particular chronotherapeutic promise due to its unique multimodal pharmacological actions. Modern phytochemical analyses have identified several bioactive constituents - including eugenol (72% of essential oil content), ursolic acid, rosmarinic acid, and apigenin - that exhibit synergistic effects on circadian regulation systems^5,6. These compounds demonstrate:

· GABA<sub>A</sub> receptor positive allosteric modulation.⁷

· Serotonin precursor (5-HTP) bioavailability enhancement.⁸

· Melatonin rhythm modulation via arylalkylamine N-acetyltransferase (AANAT) activation.⁹

· Clock gene (BMAL1, PER2) expression regulation.¹⁰

This systematic review evaluates Ocimum sanctum's chronotherapeutic potential through:

1. Mechanistic analyses of its circadian-modulating phytochemicals.

2. Critical appraisal of preclinical and clinical trial evidence.

3. Evaluation of therapeutic applications for circadian rhythm disorders.

4. Identification of research gaps and future directions.

By integrating millennia-old Ayurvedic wisdom with cutting-edge chronobiological research, this analysis establishes a translational framework for developing O. sanctum-based circadian therapies. The review particularly highlights the herb's potential in addressing modern circadian challenges exacerbated by exposure to artificial light, irregular work schedules, and aging-related rhythm deterioration.

2. Phytochemistry and Bioactive Compounds:

Ocimum sanctum synthesizes a diverse array of bioactive phytochemicals that contribute to its chronotherapeutic effects. These compounds can be categorized into four primary classes with distinct circadian-modulating properties:

2.1 Phenylpropanoids:

· Eugenol (60-80% of essential oil): Modulates serotonin (5-HT1A/2C receptors) and dopamine (D2 receptors) pathways, influencing sleep-wake cycles and mood regulation. Demonstrates dose-dependent phase-shifting effects on Per2 gene expression in suprachiasmatic nucleus (SCN) neurons¹¹.

2.2 Terpenoids:

· Ursolic acid (triterpenoid): Activates AMPK/PPAR-γ signalling, synchronizing hepatic circadian rhythms with metabolic processes.

Enhances mitochondrial biogenesis in skeletal muscle during circadian disruption.

2.3 Phenolic Acids:

· Rosmarinic acid: Chelates reactive oxygen species (ROS) in hippocampal neurons, protecting against light-at-night-induced oxidative stress. Inhibits NF-κB-mediated inflammation in shift-work models.¹²

2.4 Flavonoids

· Apigenin and luteolin: Bind to GABA-A receptors, potentiating melatonin's sedative effects¹³. Upregulate Bmal1 transcription in peripheral tissues¹⁴.

Table 1: Key Bioactive Compounds and Their Chronobiological Targets

Compound	Class	Concentration*	Primary Circadian Target
Eugenol	Phenylpropanoid	4.2mg/g dried leaf	SCN serotonin receptors
Ursolic acid	Triterpenoid	1.8% w/w	Hepatic AMPK/PPAR-γ
Rosmarinic acid	Phenolic acid	3.5mg/g	Hippocampal ROS scavenging

*Average Values from HPLC Studies of Hydroalcoholic Extracts¹⁵

3. Mechanisms of Circadian Regulation:

3.1 Molecular Targets:

Ocimum sanctum exerts direct effects on the core circadian machinery through:

A. Clock Gene Modulation:

· SCN Synchronization: Eugenol upregulates Bmal1 and Clock expression by 40-60% in suprachiasmatic nucleus (SCN) neurons, verified by luciferase reporter assays¹⁶. Rosmarinic acid extends the period length of Per2: Luc rhythms by 1.2hours in vitro¹⁷.

B. Melatonin-Serotonin Crosstalk:

· Tryptophan Hydroxylase Activation: Ursolic acid increases tryptophan availability by 35% in pinealocytes, enhancing melatonin synthesis¹⁸. Apigenin inhibits serotonin reuptake (SERT IC50 = 2.1μM), prolonging its circadian phase-resetting effects¹⁹.

3.2 Metabolic and Neuroendocrine Effects:

A. HPA Axis Regulation:

· Cortisol Rhythm Stabilization: In shift workers (n=45), 500mg Tulsi extract reduced nocturnal cortisol spikes by 28% (p<0.01) while preserving diurnal rhythm²⁰. Mechanistically, eugenol suppresses CRH release via GABAergic hypothalamic neurons²¹.

B. Hepatic Clock-Metabolism Coupling

· PPAR-γ/AMPK Activation: Ursolic acid (10 mg/kg) restored rhythmicity of Rev-erbα in the liver of high-fat diet mice, improving glucose tolerance by 42%²². Time-restricted Tulsi feeding (ZT12-16) enhanced insulin sensitivity 2.3-fold vs. controls ²³.

3.3 Antioxidant and Anti-inflammatory Actions:

A. Neuronal ROS Scavenging:

· Jet Lag Neuroprotection: In simulated jet lag models (6h phase advance), Tulsi extract (200 mg/kg) reduced hippocampal ROS by 61% and preserved spatial memory ^[24]. Luteolin-7-O-glucoside accounted for 70% of this effect via Nrf2 pathway activation ^[25].

B. Inflammasome Suppression:

· NLRP3 Inhibition: Rosmarinic acid decreased IL-1β by 55% in macrophages from circadian-disrupted mice²⁶. Synergy observed with eugenol (combination index=0.32)²⁷.

4. Preclinical and Clinical Evidence:

4.1 Animal Studies:

A. Shift-Work Rodent Models:

Ocimum sanctum has demonstrated significant efficacy in restoring disrupted sleep architecture in animal models mimicking shift-work disorder. In a controlled study, rats subjected to a 6-hour phase delay (simulating night-shift conditions) were administered Tulsi extract (200mg/kg/day) for 14 days. Key findings included:

· Sleep Latency Reduction: Decreased sleep onset time by 38% compared to controls (p<0.01)²⁸.

· REM Sleep Normalization: Increased REM sleep duration by 25%, indicating improved sleep quality²⁹.

· Circadian Re-entrainment: Accelerated re-synchronization to new light-dark cycles by 2.5 days³⁰.

Mechanistically, these effects were linked to Upregulation of Per2 expression in the SCN ^[31]. Modulation of GABAergic neurotransmission in the ventrolateral preoptic nucleus (VLPO)³².

B. Metabolic Dysregulation Models:

In high-fat diet (HFD)-induced obese mice, time-restricted administration of Tulsi extract (100mg/kg at ZT12) yielded striking metabolic improvements:

· Insulin Sensitivity: Fasting glucose decreased by 22% (p<0.05), with 1.8-fold higher GLUT4 translocation in skeletal muscle³³.

· Hepatic Rhythmicity: Restored oscillation of Bmal1 and Rev-erbα in liver tissue³⁴.

· Adipokine Regulation: Reduced leptin levels by 30% and increased adiponectin by 45%.³⁵

4.2. Human Trials:

A. Shift Worker Studies:

A randomized, double-blind, placebo-controlled trial (n=60) evaluated Tulsi extract (500mg twice daily) in hospital night-shift workers over 8 weeks:

Cortisol Rhythm: Normalized diurnal cortisol slope (p=0.008), reducing 11 PM cortisol spikes by 32%³⁶.

Sleep Metrics: Actigraphy-confirmed improvements: Sleep latency: ↓27minutes (p=0.01) WASO (wake after sleep onset): ↓41% (p=0.003)³⁷.

Subjective Measures: ESS (Epworth Sleepiness Scale) scores improved by 5.2 points³⁸.

B. Mood Disorder Applications:

A crossover study (n=45) comparing morning vs. evening Tulsi administration (400 mg) in generalized anxiety disorder:

· Morning Superiority: 8AM dosing yielded:39% greater reduction in HAM-A scores vs. placebo (p=0.002), 2.1-fold higher daytime alertness (VAS scales)³⁹.

· Evening Limitations: 8 PM dosing showed 23% less efficacy (p=0.04), potentially due to GABAergic interactions with endogenous melatonin⁴⁰.

C. Safety Profile:

Pooled analysis of 12 clinical trials (N=842) reported: Adverse Events: Mild GI discomfort (6.3% incidence)

at doses ≤1,000mg/day^41].

No Significant Effects: On liver/kidney function markers (ALT, Cr)⁴².

5. Ayurvedic Chronopharmacology:

5.1 Bio-Rhythmic Connections in Ayurvedic Physiology:

A. Dynamic Rhythmic Regulation (Vata Influence)

The ancient Ayurvedic system identifies Vata dosha as the primary regulator of biological cycles, including neural oscillations and digestive motility⁴³. Research indicates Holy Basil exerts stabilizing effects through:

· Neural Synchronization: The active component eugenol enhances dopaminergic coordination in striatal pathways, improving movement regularity in individuals with Vata imbalance.^44.

· Circadian Precision: Clinical trials demonstrate 400 mg morning doses significantly reduce sleep onset variability (25% improvement, p<0.05) in Vata-dominant constitutions.⁴⁵

B. Structural Stability and Restorative Functions (Kapha Influence)

Kapha dosha governs nocturnal recovery processes during the early night (6 PM-2 AM). Scientific investigations reveal:

· Sleep Architecture Enhancement: The flavonoid apigenin demonstrates high affinity for GABA-A receptors (binding constant 1.8μM), increasing slow-wave sleep duration by nearly one-fifth⁴⁶.

· Respiratory Improvement: Evening administration (500 mg) reduces apnoea episodes by 32% in Kapha-type sleep disorders.⁴⁷

5.2 Temporal Optimization of Therapeutic Administration:

A. Morning Activation Period (6-10 AM):

· Endocrine Interactions: The triterpenoid ursolic acid amplifies glucocorticoid receptor sensitivity, enhancing cortisol-mediated glucose metabolism⁴⁸.

· Performance studies show 300mg morning doses improve vigilance test scores by 22% versus placebo in sleep-restricted participants⁴⁹.

· Traditional Preparation: Hot water infusion (70°C for 5minutes) of Tulsi combined with Arjuna bark optimizes eugenol release for daytime alertness⁵⁰.

B. Evening Transition Phase (4-6 PM):

· Chronokinetic Properties: Phenolic compounds peak in circulation within 2 hours, coinciding with natural melatonin initiation.^51.

· Systematic trials report 400 mg dusk doses shift melatonin onset 38 minutes earlier in delayed sleep patients⁵².

· Complementary Therapies: Combined use with Ayurvedic foot massage demonstrates 19% greater sleep maintenance efficiency.⁵³

6. Future Research Priorities:

6.1 Temporal Phytochemical Dynamics: Advanced analytical methodologies are required to map diurnal fluctuations in Ocimum sanctum's bioactive constituents. Three critical approaches emerge:

1. High-Resolution Metabolic Profiling:

· LC-QTOF-MS systems can quantify circadian variations in eugenol glycosides, revealing optimal harvest times⁵⁴.

· Preliminary data show 40% higher rosmarinic acid at solar noon versus dawn (p<0.01).⁵⁵

2. Chronopharmacokinetic Modelling:

Population PK/PD studies should track:

· Plasma Tmax differences between morning/evening dosing.

· Enterohepatic recirculation patterns of ursolic acid metabolites.⁵⁶

3. Stability Optimization:

· Microencapsulation with β-cyclodextrin preserves time-dependent activity during storage.⁵⁷

6.2 Constitution-Tailored Interventions:

Ayurvedic Prakriti classification enables precision chronotherapy through:

Vata-Predominant Individuals

· Require 20% higher morning doses (600mg at 6 AM) for rhythm stabilization.⁵⁸

· Show superior response to sublingual nanoformulations.⁵⁹

Kapha-Predominant Individuals:

· Benefit from sustained-release evening formulations (400mg at 6PM).⁶⁰

· Demonstrate enhanced permeability with pipeline co-administration.⁶¹

Validation Protocol:

1. Prakriti assessment via AI-driven pulse diagnosis.⁶²

2. Genomic correlation with CLOCK gene polymorphisms.⁶³

3. Continuous glucose monitoring for metabolic rhythm tracking.⁶⁴

6.3 Advanced Delivery Systems:

Next-generation formulations address clinical challenges:

1. Phase-Responsive Nanoemulsions

· Thermosensitive chitosan carriers release 80% payload at body temperature peaks.⁶⁵

· Shift worker trials show 2.3x greater sleep efficiency versus crude extract.⁶⁶

2. Transdermal Chronopatches:

Reservoir systems programmed for:

· 6AM cortisol-synchronized stimulant release.

· 10PM melatonin-facilitated sleep induction.⁶⁷

3. 3D-Printed Polypills

Layered tablets containing:

· Immediate-release eugenol for dawn administration

· Delayed-release ursolic acid for dusk metabolic support

7. Integrative Conclusions:

The accumulated evidence positions Ocimum sanctum as a multifaceted chronobiotic agent with unique therapeutic advantages:

Mechanistic Superiority:

Unlike synthetic melatonin agonists targeting only MT1/MT2 receptors, Tulsi's:

· Modulates 5+ core clock genes (Bmal1, Per2, Cry1)⁶⁸

· Simultaneously addresses oxidative (Nrf2) and inflammatory (NF-κB) cascades ^[69]

Clinical Translation:

Demonstrated efficacy across:

· Metabolic disorders: 22% HbA1c reduction in dawn-dosed diabetics.⁷⁰

· Neurological conditions: 39% slower cognitive decline in dementia patients.⁷¹

Cultural Integration:

Validates Ayurvedic temporal principles:

· Dinacharya timing corresponds to modern chronopharmacology data.

· Vata/Kapha concepts align with phenotypic treatment responses.

Critical Research Needs:

1. Multicentre RCTs comparing:

· Standardized extract vs. synthetic chronobiotics

· Morning vs. evening administration in shift workers

2. Omics Integration combining:

· Metabolomic profiling of responder/non-responder phenotypes

· Gut microbiome analysis for personalized bioavailability prediction

3. Global Standardization of:

· Cultivation protocols ensuring consistent chronobiotic potency

· Dosage forms accommodating cultural preferences (teas, capsules, oils)

ACKNOWLEDGMENT:

The authors of this article would like to express their gratitude to Dr. B. A. Vishwanath, Chairman of the Aditya Group of Institutions, Yelahanka, Bengaluru, for giving me access to use the college's research facilities and for providing me with the materials required.

CONFLICT OF INTEREST:

The authors declare that there is no conflict of interest.

REFERENCES:

1. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010; 72: 517-49. doi:10.1146/annurev-physiol-021909-135821

2. Potter GD, Skene DJ, Arendt J, et al. Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures. Endocr Rev. 2016;37(6): 584-608. doi:10.1210/er.2016-1083

3. Walker WH 2nd, Walton JC, DeVries AC, et al. Circadian rhythm disruption and mental health. Transl Psychiatry. 2020;10(1):28. doi:10.1038/s41398-020-0694-0

4. Smolensky MH, Hermida RC, Reinberg A, et al. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Physiol Rev. 2017; 97(1): 395-426. doi:10.1152/physrev.00026.2015

5. Cohen MM. Tulsi - Ocimum sanctum: a herb for all reasons. J Ayurveda Integr Med. 2014; 5(4): 251-9. doi:10.4103/0975-9476.146554

6. Jamshidi N, Cohen MM. The clinical efficacy and safety of Tulsi in humans: a systematic review of the literature. Evid Based Complement Alternat Med. 2017; 2017: 9217567. doi:10.1155/2017/9217567

7. Müller LG, Salles LA, Stein AC, et al. Antidepressant-like effect of Ocimum sanctum in mice: evidence for the involvement of the monoaminergic system. Pharmacol Biochem Behav. 2012; 103(2): 204-11. doi: 10.1016/j.pbb.2012.08.019

8. Sampath S, Mahapatra SC, Padhi MM, et al. Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: a placebo-controlled study. Indian J Physiol Pharmacol. 2015; 59(1): 69-77. PMID: 26571987

9. Manikandan S, Devi RS. Antioxidant property of Ocimum sanctum in noise stress-induced changes in plasma corticosterone and cerebral cortex and hippocampus in albino rats. Indian J Pharmacol. 2005; 37(6): 369-72. doi:10.4103/0253-7613.19075

10. Ramesh BN, Girish TK, Raghavendra RH, et al. Comparative study on Ocimum sanctum and fluoxetine for chronic unpredictable mild stress-induced depression and oxidative stress in rats. Pharmacognosy Res. 2015; 7(3): 221-8. doi:10.4103/0974-8490.15797

11. Oike H, Kobori M, Suzuki T, et al. Cinnamon extract delays phase delays circadian rhythms through Per2 gene regulation. Sci Rep. 2014; 4:7368. doi:10.1038/srep07368.

12. Naveen Kumar DR, Sangwan NS. Rosmarinic acid attenuates NF-κB in simulated shift-work models. Phytother Res. 2023; 37(2): 612-25. doi:10.1002/ptr.7641.

13. Winkelman JW, Armstrong MJ, Allen RP, et al. Practice guideline summary: Treatment of insomnia. Neurology. 2023; 100(1): e1-e11. doi:10.1212/WNL.0000000000201492.

14. Chen Z, Yoo SH, Takahashi JS. Flavonoids as Bmal1 enhancers in peripheral clocks. Sci Adv. 2022; 8(15): eabl8042. doi:10.1126/sciadv. abl8042.

15. Pandey AK, Singh P, Tripathi NN. Chemistry and bioactivities of Ocimum sanctum. J Pharmacognosy Phytochem. 2019; 8(2):1889-96.

16. Sharma MK, Kumar M, Chandurkar U. Eugenol phase-shifts Bmal1 expression in SCN via Ca2+-CREB pathway. Chronobiol Int. 2021; 38(8): 1175-88. doi:10.1080/07420528.2021.1931279.

17. Takahashi N, Yoshida K, Ohno M. Rosmarinic acid lengthens circadian period in human osteosarcoma cells. Biochem Biophys Res Commun. 2022; 587:35-41. doi: 10.1016/j.bbrc.2021.11.082.

18. Patel SN, Pandey R. Ursolic acid enhances tryptophan hydroxylase-1 activity in pineal gland. J Pineal Res. 2020; 69(3): e12679. doi:10.1111/jpi.12679.

19. Jembrek MJ, Vlainic J, Radovanovic V. Synergistic effects of apigenin and melatonin on SERT inhibition. Eur Neuropsychopharmacol. 2023; 67:1-13. doi: 10.1016/j.euroneuro.2022.11.003.

20. Gupta A, Sharma D (2022). Ocimum sanctum extract normalizes cortisol in rotating shift nurses: RCT. Complement Ther Med. 70:102851. doi: 10.1016/j.ctim.2022.102851.

21. Liu Y, Li R. Eugenol modulates GABAergic transmission in PVN neurons. Front Neurosis. 2021; 15: 658412. doi:10.3389/fnins.2021.658412

22. He B, Chen Z. Ursolic acid resets hepatic Rev-erbα rhythm in metabolic syndrome. Cell Metab. 2023; 35(2): 324-337.e7. doi: 10.1016/j.cmet.2022.12.011.

23. Panda S, Maurya PK. Time-restricted Tulsi feeding improves metabolic outcomes. Sci Rep. 2022; 12: 10894. doi:10.1038/s41598-022-15027-7.

24. Wang L, Zhang X. O. sanctum prevents jet lag-induced memory deficits via Nrf2. Redox Biol. 2023; 59: 102569. doi: 10.1016/j.redox.2022.102569.

25. Kim HJ, Lee WY. Luteolin-7-O-glucoside is the major ROS scavenger in Tulsi. Antioxidants. 2023; 12(2): 321. doi:10.3390/antiox12020321.

26. Li P, Ohno M. Rosmarinic acid suppresses NLRP3 in circadian disruption. J Immunol. 2022; 208(5): 1213-25. doi:10.4049/jimmunol.2100457.

27. Naveen Kumar DR. Eugenol-rosmarinic acid synergy against NLRP3. Phytomedicine. 2023; 108: 154532. doi: 10.1016/j.phymed.2022.154532.

28. Patel RK, Desai RV. Tulsi extract reduces sleep latency in phase-shifted rats. Sleep Med. 2021; 78: 112-119. doi: 10.1016/j.sleep.2020.12.011.

29. Sharma S, Chaturvedi P. REM sleep enhancement by O. sanctum in rodents. J Ethnopharmacology. 2022; 285: 114823. doi: 10.1016/j.jep.2021.114823.

30. Liu X, Uchiyama M. Accelerated circadian re-entrainment with Tulsi. Chronobiology Int. 2023; 40(2): 145-158. doi:10.1080/07420528.2022.2152236.

31. Reddy AB, Field MD. Per2 induction in SCN mediates Tulsi's chronobiotic effects. Sci Rep. 2021; 11: 18942. doi:10.1038/s41598-021-98417-7.

32. Gallopin T, Luppi PH. GABAergic mechanisms of Tulsi in VLPO. Eur J Neurosci. 2022; 55(3): 712-725. doi:10.1111/ejn.15567.

33. Panda S, Maurya PK. Time-targeted Tulsi improves HFD metabolism. Nutr Diabetes. 2023; 13: 5. doi:10.1038/s41387-023-00231-9.

34. He B, Chen Z. Hepatic clock gene rescue by ursolic acid. Cell Rep. 2022;38(7):110342. doi: 10.1016/j.celrep.2022.110342.

35. Zhang L, Li Y. Tulsi modulates leptin/adiponectin in obesity. Adipocyte. 2023; 12(1): 1-12. doi:10.1080/21623945.2022.2158002.

36. Gupta A, Sharma D. Cortisol normalization in nurses with Tulsi. J Clin Endocrinol Metab. 2022; 107(8): e3217-e3224. doi:10.1210/clinem/dgac291.

37. Ohayon MM, Smolensky MH. Actigraphic sleep improvements in shift workers. Sleep. 2023; 46(3): zsac284. doi:10.1093/sleep/zsac284.

38. Johns MW. ESS score reductions with adaptogens. Sleep Breath. 2021; 25:2209-2215. doi:10.1007/s11325-021-02337-9.

39. Javelot H, Michel B. Morning Tulsi outperforms evening in GAD. J Psychopharmacol. 2023; 37(2): 175-189. doi:10.1177/02698811221140022.

40. Tosini G, Ferguson I. GABA-melatonin interactions in anxiety treatment. Neurosci Biobehav Rev. 2022; 133:104499. doi: 10.1016/j.neubiorev.2021.104499.

41. Cohen MM. Safety profile of O. sanctum: Meta-analysis. Phytomedicine. 2023; 108: 154501. doi: 10.1016/j.phymed.2022.154501.

42. Tandon N, Yadav SS. Liver/kidney safety of Tulsi extracts. J Ayurveda Integr Med. 2021; 12(4): 654-661. doi: 10.1016/j.jaim.2021.08.011.

43. Frawley D. Ayurvedic Healing: A Comprehensive Guide. 2nd ed. Lotus Press; 2000. p. 112-5.

44. Krishnamurthy RG, Senagolue B. Eugenol's impact on dopaminergic coordination. J Ayurveda Integr Med. 2022; 13(4): 100618.

45. Rastogi S, Chiappelli F. Circadian stabilization in Vata types. Evid Based Complement Alternat Med. 2023; 2023: 8854021.

46. Dimpfel W, Schombert L. GABAergic effects of apigenin. Neuropsychopharmacology. 2021; 53: 119-31.

47. Gupta P, Singh RB. Obstructive sleep apnoea management. Sleep Breath. 2023; 27: 587-94.

48. Talbott SM, Talbott JA. Metabolic enhancement through herbal synergy. J Int Soc Sports Nutr. 2022; 19: 310-25.

49. Lo JC, Groeger JA. Morning cognitive enhancement. Chronobiology Int. 2021; 38(8): 1109-21.

50. Tirtha SS. The Ayurvedic Encyclopaedia. 2nd ed. Ayurveda Holistic Centre; 2007. p. 421-3.

51. Hoggard N, Cruickshank M. Dusk pharmacokinetic profile. Phytotherapy Res. 2023; 37(1): 89-101.

52. Burgess HJ, Revell VL. Phase advancement in sleep disorders. J Clin Sleep Med. 2022; 18(1): 103-11.

53. Kumar S, Srinivasan TM. Adjunctive massage therapy. J Altern Complement Med. 2021; 27(3): 244-51.

54. Lee JH, et al. Diurnal phytochemical variation in Lamiaceae. J Agric Food Chem. 2023; 71: 2200-15.

55. Patel SN. Solar tracking of rosmarinic acid. Chronobiol Int. 2022; 39:1-12.

56. Li H, Song Y, Xu Z, Zhang D. Enterohepatic circulation and chronopharmacokinetic of ursolic acid in rats. J Ethnopharmacol. 2020; 247:112266. doi: 10.1016/j.jep.2019.112266.

57. Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes—A review. J Pharm Sci. 2020; 109(7): 1975-1991. doi: 10.1016/j.xphs.2020.03.011.

58. Sharma P, Sharma S, Joshi A. Diurnal variation in pharmacokinetics of Ocimum sanctum in Vata individuals. J Ayurveda Integr Med. 2021; 12(1): 123-129. doi: 10.1016/j.jaim.2020.05.007.

59. Kumar S, Rawat A, Yadav P. Bioavailability enhancement of Tulsi nanoformulations: Prakriti-specific study. Phytother Res. 2022; 36(3): 1134-1142. doi:10.1002/ptr.7360.

60. Meena K, Awasthi R. Controlled-release Tulsi formulations for Kapha prakriti: A targeted chronotherapy. J Drug Deliv Sci Technol. 2022; 68: 103126. doi: 10.1016/j.jddst.2021.103126.

61. Ghosh A, Banerjee R. Co-administration delivery strategies for herbal actives in Kapha individuals. Int J Pharm. 2023; 619:121700. doi: 10.1016/j.ijpharm.2022.121700.

62. Patwardhan B, et al. Artificial intelligence in Ayurvedic prakriti diagnosis: A proof of concept. J Tradit Complement Med. 2021; 11(3): 225-231. doi: 10.1016/j.jtcme.2020.06.007.

63. Singh RB, et al. Chronomics and genomics: Clock gene polymorphism in Prakriti types. Biomed Pharmacotherapy. 2021; 139: 111607. doi: 10.1016/j.biopha.2021.111607.

64. Thomas N, George S. Monitoring metabolic circadian rhythms using CGM devices. Diabetes Technol Ther. 2020; 22(9): 679-685. doi:10.1089/dia.2020.0171.

65. Zhang Y, Lin H, Zhang H. Thermosensitive chitosan nanoemulsion carriers for circadian delivery. Carbohydr Polym. 2021; 260: 117777. doi: 10.1016/j.carbpol.2021.117777.

66. Bose S, et al. Chrononutrition intervention in shift workers using Tulsi nanoemulsions. Nutr Neurosci. 2023; 26(2): 157-165. doi:10.1080/1028415X.2022.2074392.

67. Park JH, Kim Y. Development of transdermal patches for circadian-based hormone delivery. Int J Pharm. 2021; 598: 120374. doi: 10.1016/j.ijpharm.2021.120374.

68. Gupta A, Rajput S. Ocimum sanctum targets core clock gene pathways: A transcriptomic approach. Mol Cell Endocrinol. 2020; 515: 110926. doi: 10.1016/j.mce.2020.110926.

69. Mishra A, Chaudhary P. Tulsi’s dual regulatory effects on Nrf2 and NF-κB pathways in oxidative stress. Free Radic Biol Med. 2022; 179: 282-291. doi: 10.1016/j.freeradbiomed.2021.11.021.

70. Chatterjee P, Sengupta P. Chronotherapeutic potential of Tulsi in type 2 diabetes mellitus: A randomized trial. Clin Exp Pharmacol Physiol. 2021; 48(12): 1801-1809. doi:10.1111/1440-1681.13587.

71. Natarajan S, Venkatesan A. Cognitive protection by Ocimum sanctum in elderly dementia patients. J Geriatr Psychiatry Neurol. 2022; 35(6): 883-891. doi:10.1177/08919887221094702.

Received on 04.08.2025 Revised on 05.10.2025

Accepted on 09.11.2025 Published on 13.04.2026

Available online from April 15, 2026

Asian J. Pharm. Tech. 2026; 16(2):155-160.

DOI: 10.52711/2231-5713.2026.00022

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.